Taro Funakoshi
Kyoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Population pharmacokinetic analysis of bevacizumab in Japanese cancer patients with proteinuria: a prospective cohort study.
Journal: Cancer chemotherapy and pharmacology
Published: October 18, 2024
Real-world outcomes of FOLFOXIRI plus bevacizumab in patients with metastatic colorectal cancer: the JSCCR-TRIPON study.
Journal: International journal of clinical oncology
Published: June 02, 2024
Efficacy of Magnesium Supplementation in Cancer Patients Developing Hypomagnesemia Due to Anti-EGFR Antibody: A Systematic Review.
Journal: Cancer diagnosis & prognosis
Published: March 20, 2024
Low serum concentrations of bevacizumab and nivolumab owing to excessive urinary loss in patients with proteinuria: a case series.
Journal: Cancer chemotherapy and pharmacology
Published: December 26, 2023
Proteinuria frequency and subsequent renal dysfunction in bevacizumab-treated patients: a single center, retrospective, observational study.
Journal: International journal of clinical oncology
Published: September 02, 2023
Medical care costs according to the stage and subtype of breast cancer in a municipal setting: a case study of Hachioji City, Japan.
Journal: Breast cancer (Tokyo, Japan)
Published: August 31, 2023
Removal rate of 5-fluorouracil and its metabolites in patients on hemodialysis: a report of two cases of colorectal cancer patients with end-stage renal failure.
Journal: Cancer chemotherapy and pharmacology
Published: April 16, 2023
Association between homologous recombination gene variants and efficacy of oxaliplatin-based chemotherapy in advanced pancreatic cancer: prospective multicenter observational study.
Journal: Medical oncology (Northwood, London, England)
Published: February 27, 2023
Effect of Severe Renal Dysfunction on the Plasma Levels of DNA-Reactive Platinum after Oxaliplatin Administration.
Journal: Biological & pharmaceutical bulletin
Published: February 01, 2023
Use of Cabozantinib to Treat MET -amplified Pediatric Colorectal Cancer.
Journal: Journal of pediatric hematology/oncology
Published: January 27, 2022
Last Updated: 09/26/2026